Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice

Drugs Exp Clin Res. 1996;22(2):35-40.

Abstract

Conophylline, a new vinca alkaloid isolated from the plant Ervatamia microphylla induced normal flat morphology in K-ras-NRK and K-ras-NIH cell lines, and lowered the increased uptake of 2-deoxyglucose in K-ras-NRK cells. Conophylline inhibited the growth of K-ras-NRK cells, but this inhibition was reversible. The alkaloid also inhibited the growth of K-ras-NRK and K-ras-NIH3T3 tumours transplanted into nude mice. On the other hand, it showed no effect on survival of the mice loaded with L1210 leukaemia. Thus, conophylline is a new antitumour vinca alkaloid that induced normal phenotypes in ras-expressing cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Cattle
  • Drug Screening Assays, Antitumor
  • Female
  • Genes, ras / drug effects*
  • In Vitro Techniques
  • Mice
  • Mice, Nude
  • Tumor Cells, Cultured / drug effects
  • Vinca Alkaloids / chemistry
  • Vinca Alkaloids / isolation & purification
  • Vinca Alkaloids / pharmacology*

Substances

  • Antineoplastic Agents, Phytogenic
  • Vinca Alkaloids
  • conophylline